Nutex Health Inc. (NASDAQ:NUTX) Receives Consensus Rating of “Moderate Buy” from Analysts

Nutex Health Inc. (NASDAQ:NUTX) has been assigned a consensus recommendation of “Moderate Buy” from the five research firms that are presently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $268.3333.

NUTX has been the subject of a number of analyst reports. Weiss Ratings upgraded shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, July 28th. B. Riley Financial assumed coverage on Nutex Health in a report on Friday, June 26th. They issued a “buy” rating and a $290.00 price objective for the company. Lake Street Capital reiterated a “buy” rating and set a $310.00 target price (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. Wall Street Zen lowered Nutex Health from a “strong-buy” rating to a “buy” rating in a report on Monday, July 20th. Finally, Zacks Research raised Nutex Health to a “hold” rating in a research note on Monday, June 29th.

Nutex Health Trading Up 1.6%

Shares of Nutex Health stock opened at $190.62 on Thursday. The business has a fifty day simple moving average of $165.64 and a two-hundred day simple moving average of $130.79. Nutex Health has a 1 year low of $77.21 and a 1 year high of $204.00. The company has a market capitalization of $1.31 billion, a price-to-earnings ratio of 7.48 and a beta of 0.24. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, beating the consensus estimate of $4.95 by $4.43. The firm had revenue of $210.75 million for the quarter, compared to analysts’ expectations of $215.03 million. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. Research analysts forecast that Nutex Health will post 30.11 EPS for the current year.

Hedge Funds Weigh In On Nutex Health

A number of institutional investors have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new stake in shares of Nutex Health in the second quarter worth $69,612,000. Pertento Partners LLP grew its stake in Nutex Health by 20.0% during the fourth quarter. Pertento Partners LLP now owns 324,422 shares of the company’s stock worth $53,406,000 after purchasing an additional 54,001 shares during the period. Topline Capital Management LLC increased its stake in shares of Nutex Health by 72.0% in the 2nd quarter. Topline Capital Management LLC now owns 309,131 shares of the company’s stock valued at $38,484,000 after acquiring an additional 129,418 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of Nutex Health by 12.7% during the 3rd quarter. Vanguard Group Inc. now owns 214,954 shares of the company’s stock valued at $22,209,000 after acquiring an additional 24,275 shares during the period. Finally, Millennium Management LLC lifted its position in shares of Nutex Health by 191.1% during the 3rd quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock valued at $9,650,000 after acquiring an additional 61,308 shares during the period. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight?loss services and behavioral health support. By combining in?person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost?effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail?anchored centers, offering treatment for non?life?threatening injuries and illnesses, preventive screenings and basic primary care.